Concepedia

Shoshy Alam Brinch

SA

Statistics

Publications

5

Citations

155

H-Index

5

Active since

2020

Affiliations

University of Oslo(Current)

Oslo University Hospital

University of Oulu

Leibniz-Forschungsinstitut für Molekulare Pharmakologie

Høyskolen Kristiania

Shoshy Alam Brinch is an author at University of Oslo specializing in pharmacology, tyrosine kinase inhibitors, and molecular oncology.

Publications per year

2020–2022

5

Publications

5

Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models

Jo Waaler, Line Mygland, Anders Tveita et al. · Communications Biology · 2020 · 55 citations · Full text

, , +17

Preclinical Lead Optimization of a 1,2,4-Triazole Based Tankyrase Inhibitor

Jo Waaler, Ruben G.G. Leenders, Sven T. Sowa et al. · Journal of Medicinal Chemistry · 2020 · 41 citations · Full text

, , +17

Development of a 1,2,4-Triazole-Based Lead Tankyrase Inhibitor: Part II

Ruben G.G. Leenders, Shoshy Alam Brinch, Sven T. Sowa et al. · Journal of Medicinal Chemistry · 2021 · 23 citations · Full text

, , +16

The Tankyrase Inhibitor OM-153 Demonstrates Antitumor Efficacy and a Therapeutic Window in Mouse Models

Shoshy Alam Brinch, Enya Amundsen-Isaksen, Sandra Espada et al. · Cancer Research Communications · 2022 · 19 citations · Full text

, , +17

Identification of response signatures for tankyrase inhibitor treatment in tumor cell lines

Line Mygland, Shoshy Alam Brinch, Martin Frank Strand et al. · iScience · 2021 · 17 citations · Full text

, , +17

1–5 of 5